You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples
SBC: SPECTRAL ENERGIES LLC Topic: CBD181006We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Dual Formulation of Atropine/Scopolamine with Enhanced Stability
SBC: CMC PHARMACEUTICALS INC Topic: CBD181005CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
AOTF-based Spectral Imaging for Enhanced Stand-off Chemical Detection
SBC: DRS SCIENTIFIC, INC. Topic: CBD13104DRS Scientific proposes a new type of Acousto-Optic Tuned Filter (AOTF) polarimetric hyperspectral imager that is compact, rugged, and inexpensive, has no moving parts, is free of optical aberrations, and is fast and sensitive. It will cover 8-12 mm with 8 cm-1 spectral resolution or finer, and will have mFlick sensitivity with a cooled camera, and
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
Microfiber-Based Closures with Hermetic Sealing for Chem Bio Protective Garments
SBC: NANOGRIPTECH Topic: CBD13109Hook and loop closures in Army uniforms have been identified as the critical sources of leaks in protective clothing/equipment, which limits the overall protective capability of the ensemble. New closure systems capable of providing both the shear and peel strengths demonstrated by hook and loop systems as well as hermetic sealing against any vapor permeation across the closure need to be develope ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
Development of a long-acting, injectable controlled release butyrylcholinesterase formulation using predictive modeling.
SBC: Qrono, Inc. Topic: CBD13107Elevated levels of human butyrylcholinesterase (BuChE) confer protection from chemical warfare nerve agents and other organophosphorous chemicals. As a prophylactic, the key to enabling this protection is the ability to maintain elevated concentrations of BuChE in the plasma for days or weeks. Thus far, plasma-derived and PEGylated recombinant forms of BuChE have been tested in humans. However, ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
Rapid Sample Transport in Austere Environments
SBC: PIASECKI AIRCRAFT CORP Topic: CBD12108Piasecki Aircraft proposes to meet the challenge of delivering a biological or chemical sample maintained at less than -20 deg Celcius over a range of up to 1000 miles with a precision landing with a portable unmanned aerial system capable of a vertical takeoff, cruise flight range typical of a fixed wing platform, and able to perform a precision landing. The system consists of a lifting quadrotor ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
An automated, high throughput, resin-free device for large scale protein purification
SBC: CFD RESEARCH CORPORATION Topic: CBD12102Protein manufacturing is of paramount importance to chemical and biological defense applications. High-throughput protein purification is a critical need for rapidly scaling the target protein product. Existing purification methods primarly rely on synthetic-resin based chromatography, which is time-consuming, labor-intensive, expensive, and consequently, ill-suited for developing rapid countermea ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
A Novel, Aerodynamics-augmented Continuous Ionization System for Electrostatic Collection of Bioaerosols
SBC: CFD RESEARCH CORPORATION Topic: CBD12107Safe and efficient air ionization and filtration technology compatible to biodefense applications is of paramount importance. Current ionization methods are energy-intensive, costly, prone to ozone generation, or inefficient, and consequently ill-suited for building protection applications. To overcome these issues, we propose to develop and demonstrate a novel bioaerosol ionization and collection ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
AC Impedance Sensor for Collective Protection Filter Residual Life Indicator
SBC: GUILD ASSOCIATES INC Topic: CBD10106Guild Associates, Inc. proposes to develop and evaluate an active electrochemical sensor based residual life indicator (RLI) for adsorptive carbon filters. The sensing system of the RLI will operate by analyzing the electrochemical state of the carbon within the filter and evaluate the remaining adsorptive reactive capacities of the filter. The sensor design will be challenged against an array of ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
A Novel Microfludic Device for Drug Toxicity Studies
SBC: CFD RESEARCH CORPORATION Topic: CBD10103Current drug discovery and development programs are severely limited by the expensive animal trials and oversimplified in vitro models. Results obtained from the in vitro models are not predictive of in vivo toxicity owing to significant difference in testing from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device for quantitati ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense